- Home
- SIF vs VYNE Comparison
SIF vs VYNE Comparison
Compare SIF & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- VYNE
- Stock Information
- Founded
- SIF 1913
- VYNE 2003
- Country
- SIF United States
- VYNE United States
- Employees
- SIF N/A
- VYNE N/A
- Industry
- SIF Office Equipment/Supplies/Services
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- VYNE Health Care
- Exchange
- SIF Nasdaq
- VYNE Nasdaq
- Market Cap
- SIF 18.6M
- VYNE 16.0M
- IPO Year
- SIF N/A
- VYNE 2018
- Fundamental
- Price
- SIF $4.25
- VYNE $1.51
- Analyst Decision
- SIF
- VYNE Strong Buy
- Analyst Count
- SIF 0
- VYNE 2
- Target Price
- SIF N/A
- VYNE $6.25
- AVG Volume (30 Days)
- SIF 19.4K
- VYNE 1.2M
- Earning Date
- SIF 08-11-2025
- VYNE 08-13-2025
- Dividend Yield
- SIF N/A
- VYNE N/A
- EPS Growth
- SIF N/A
- VYNE N/A
- EPS
- SIF N/A
- VYNE N/A
- Revenue
- SIF $83,554,000.00
- VYNE $605,000.00
- Revenue This Year
- SIF N/A
- VYNE $42.51
- Revenue Next Year
- SIF N/A
- VYNE N/A
- P/E Ratio
- SIF N/A
- VYNE N/A
- Revenue Growth
- SIF 35.83
- VYNE 43.03
- 52 Week Low
- SIF $2.33
- VYNE $0.85
- 52 Week High
- SIF $5.96
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- SIF 72.23
- VYNE 60.28
- Support Level
- SIF $2.95
- VYNE $0.85
- Resistance Level
- SIF $3.89
- VYNE $1.96
- Average True Range (ATR)
- SIF 0.29
- VYNE 0.19
- MACD
- SIF 0.02
- VYNE 0.09
- Stochastic Oscillator
- SIF 100.00
- VYNE 59.46
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.